SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-006118
Filing Date
2023-03-06
Accepted
2023-03-06 08:01:06
Documents
74
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vrca-20221231.htm   iXBRL 10-K 3061500
2 EX-23.1 vrca-ex23_1.htm EX-23 5496
3 EX-31.1 vrca-ex31_1.htm EX-31 14558
4 EX-31.2 vrca-ex31_2.htm EX-31 15272
5 EX-32.1 vrca-ex32_1.htm EX-32 13990
6 GRAPHIC img253555344_0.jpg GRAPHIC 71611
  Complete submission text file 0000950170-23-006118.txt   10439829

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrca-20221231_def.xml EX-101.DEF 250569
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrca-20221231.xsd EX-101.SCH 59443
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrca-20221231_pre.xml EX-101.PRE 413571
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrca-20221231_lab.xml EX-101.LAB 562085
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrca-20221231_cal.xml EX-101.CAL 65129
68 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20221231_htm.xml XML 1745682
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38529 | Film No.: 23707608
SIC: 2834 Pharmaceutical Preparations